Sharon Karmon, MD,
The Center for Clinical and Translational Science (CCTS), The Rockefeller University
Learning Objectives:
1. Describe the nature of transmitted HIV-1 drug resistance
2. Discuss the benefits and limitations of using standard Sanger sequencing to characterize HIV-1 drug resistance mutations
3. Discuss the benefits and limitations of using ultra-deep sequencing methods to characterize HIV-1 drug resistance mutations
Sponsor:
Rockefeller University
Date/Time:
Tuesday, July 17th, 2012, 2:00 – 3:00 PM EST 
